This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Guangzhou Bio-Gene Technology Co., Ltd., Guangzhou Bio-Gene Technology Co., Ltd. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 3 
1 out of 2 Years Active: 2023-2026
Title: The Innovations of Wen Ding
Introduction
Wen Ding is a notable inventor based in Guangdong, China. He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibodies for cancer treatment. With a total of 4 patents, his work is paving the way for advancements in clinical applications.
Latest Patents
Wen Ding's latest patents include groundbreaking research on chimeric antigen receptors targeting CLL1. One of his notable inventions is an anti-CLL1 antibody, which demonstrates significant binding ability to both free and cell surface CLL1. The variable region of this antibody includes the CDRs of SEQ ID NO: 1 to 6, SEQ ID NO: 5, and SEQ ID NO: 7 to 11 or SEQ ID NO: 12 to 17. After humanization, the affinity of the antibody to CLL1 is further improved, showcasing its important application prospects in the clinical diagnosis and treatment of tumors.
Career Highlights
Wen Ding is currently associated with Guangzhou Bio-Gene Technology Co., Ltd., where he continues to innovate and develop new therapeutic solutions. His work is characterized by a commitment to enhancing the efficacy of cancer treatments through advanced antibody technology.
Collaborations
Wen collaborates with talented individuals in his field, including Guangchao Li and Min Luo, who contribute to his research endeavors.
Conclusion
Wen Ding's contributions to biotechnology and his innovative patents are making a significant impact in the fight against cancer. His work exemplifies the potential of scientific research to improve clinical outcomes and enhance patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile